Ross H. Albert

933 total citations
14 papers, 490 citations indexed

About

Ross H. Albert is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ross H. Albert has authored 14 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ross H. Albert's work include Aldose Reductase and Taurine (2 papers), Multiple Sclerosis Research Studies (2 papers) and Biochemical effects in animals (2 papers). Ross H. Albert is often cited by papers focused on Aldose Reductase and Taurine (2 papers), Multiple Sclerosis Research Studies (2 papers) and Biochemical effects in animals (2 papers). Ross H. Albert collaborates with scholars based in United States. Ross H. Albert's co-authors include T.M. Penning, Bernadette Kálmán, De Sousa, Joseph M. Jez, M. J. Bennett, Haiching Ma, Jun Yin, Bradford A. Jameson, John J. Russell and Anna P. Tretiakova and has published in prestigious journals such as Biochemistry, Structure and JAMA Internal Medicine.

In The Last Decade

Ross H. Albert

13 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross H. Albert United States 9 146 108 103 80 77 14 490
Marie‐Liesse Piketty France 17 138 0.9× 160 1.5× 294 2.9× 124 1.6× 180 2.3× 34 892
Giuseppe Albano Italy 16 54 0.4× 232 2.1× 122 1.2× 28 0.3× 87 1.1× 63 676
Stefania Bello Italy 14 58 0.4× 128 1.2× 170 1.7× 36 0.5× 31 0.4× 31 650
Hannah Parsons Canada 15 61 0.4× 170 1.6× 63 0.6× 22 0.3× 69 0.9× 33 680
Hemamalini Ketha United States 14 24 0.2× 166 1.5× 120 1.2× 236 3.0× 61 0.8× 24 728
Isabel Ibarra‐González Mexico 16 79 0.5× 415 3.8× 73 0.7× 53 0.7× 142 1.8× 76 784
Torben Leo Nielsen Denmark 19 91 0.6× 245 2.3× 318 3.1× 86 1.1× 35 0.5× 37 962
Hiroko Abe Japan 12 59 0.4× 79 0.7× 104 1.0× 30 0.4× 57 0.7× 29 515
Lael Reinstatler United States 13 33 0.2× 183 1.7× 115 1.1× 19 0.2× 67 0.9× 35 739
J. R. McRae United States 13 45 0.3× 97 0.9× 122 1.2× 22 0.3× 35 0.5× 22 566

Countries citing papers authored by Ross H. Albert

Since Specialization
Citations

This map shows the geographic impact of Ross H. Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross H. Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross H. Albert more than expected).

Fields of papers citing papers by Ross H. Albert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross H. Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross H. Albert. The network helps show where Ross H. Albert may publish in the future.

Co-authorship network of co-authors of Ross H. Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Ross H. Albert. A scholar is included among the top collaborators of Ross H. Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross H. Albert. Ross H. Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Albert, Ross H., et al.. (2023). P24 A low-cost educational platform for teaching advanced communication skills to trainees. Gynecologic Oncology. 173. S22–S23.
2.
Albert, Ross H., et al.. (2021). Management of Intractable Symptoms in Oncologic Care. Current Oncology Reports. 23(8). 93–93. 1 indexed citations
3.
Albert, Ross H.. (2017). End-of-Life Care: Managing Common Symptoms.. PubMed. 95(6). 356–361. 28 indexed citations
4.
Albert, Ross H.. (2016). Response to a Patient’s Failed Swallowing Study. JAMA Internal Medicine. 176(10). 1431–1431. 2 indexed citations
5.
Albert, Ross H.. (2010). Diagnosis and treatment of acute bronchitis.. PubMed. 82(11). 1345–50. 73 indexed citations
6.
Albert, Ross H. & John J. Russell. (2009). Evaluation of the solitary pulmonary nodule.. PubMed. 80(8). 827–31. 31 indexed citations
7.
Albert, Ross H., et al.. (2008). Cancer screening in the older patient.. PubMed. 78(12). 1369–74. 13 indexed citations
8.
Yin, Jun, Ross H. Albert, Anna P. Tretiakova, & Bradford A. Jameson. (2006). 5-HT1B receptors play a prominent role in the proliferation of T-lymphocytes. Journal of Neuroimmunology. 181(1-2). 68–81. 62 indexed citations
9.
SKOLNIK, NEIL & Ross H. Albert. (2006). Blood Pressure Measurement. Family Practice News. 36(10). 16–16. 4 indexed citations
10.
Kálmán, Bernadette, Ross H. Albert, & Thomas Leist. (2002). Genetics of Multiple Sclerosis: Determinants of Autoimmunity and Neurodegeneration. Autoimmunity. 35(4). 225–234. 19 indexed citations
11.
Sousa, De, Ross H. Albert, & Bernadette Kálmán. (2002). Cognitive impairments in multiple sclerosis: A review. American Journal of Alzheimer s Disease & Other Dementias®. 17(1). 23–29. 65 indexed citations
12.
Jin, Yi, Steven E. Stayrook, Ross H. Albert, et al.. (2001). Crystal Structure of Human Type III 3α-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein Complexed with NADP+ and Ursodeoxycholate,. Biochemistry. 40(34). 10161–10168. 86 indexed citations
13.
Albert, Ross H., et al.. (2000). HIV and injection drug use amongst First Nations in Vancouver. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026